NEUP · Neuphoria Therapeutics Inc. · Executive Compensation
Market Cap
$18.34M
Shares
5.41M
Volume · Oct 20
20.81K
Avg daily vol (3M)
159.22K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2026
| Executive | Role | Total |
|---|---|---|
| Spyros Papapetropoulos | President and Chief Executive Officer | $1,674,690 |
| Tim Cunningham | Chief Financial Officer Tim Cunningham Chief Financial Officer | $325,894 |
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Spyros Papapetropoulos | M.D., PhD President and Chief Executive Officer | $951,343 |
| Tim Cunningham | Chief Financial Officer Tim Cunningham Chief Financial Officer | $254,363 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Spyros Papapetropoulos | M.D., PhD President and Chief Executive Officer | $751,875 |
| Tim Cunningham | Chief Financial Officer Tim Cunningham Chief Financial Officer | $294,788 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Aaron Weaver | member of the Board of Directors | Resigned | 2024-10-10 |
Leadership
- Spyros Papapetropoulos CEO
- Alan Fisher Chairman
- Tim Cunningham CFO
- David Wilson Board Member
- Jane Ryan, Ph.D. Board Member
- Miles Davies Board Member